OsteoSurge 100
Our OsteoSurge® 100 grafts combine demineralized bone matrix with patented Accell® Bone Matrix in a bio-resorbable, reverse-phase medium carrier. Provided in a syringe, the putty is moldable and resists irrigation. The putty may be implanted directly from the syringe.
Key Features
Accell Technology
- The patented Accell process yields Accell bone matrix (ABM). ABM is an open-structured, dispersed form of DBM
Superior Handling
- The unique, poloxamer, reverse phase medium carrier, which becomes more viscous at body temperature, provides exceptional handling and containment characteristics. The graft is moldable, packable, mixable and resists irrigation
Verified Osteoinductive Potential
- Every lot of DBM is tested in a validated, in vitro assay to verify osteoinductive potential
Expert Processing
- Ground cortical bone and cancellous bone obtained from AATB-accredited tissue banks is processed into DBM in our state-of-the-art facility. The demineralization process is tightly controlled to consistently produce demineralized bone
Electron Beam Sterilization
- The processing of DBM and ABM is completed under aseptic conditions in our state-of-the-art facility. As the last step in manufacturing, the graft is sterilized via electron beam irradiation
Technologies
